02577nas a2200349 4500000000100000008004100001260001300042653001000055653002600065653002400091653001100115653001100126653001200137653000900149653001600158653002100174653001300195653002300208653001700231653001200248100001300260700001700273700001600290700001900306700001300325700001900338245009900357300001100456490000600467520174000473022001402213 2003 d c2003 Feb10aAdult10aArthritis, Rheumatoid10aEpiretinal Membrane10aFemale10aHumans10aleprosy10aMale10aMiddle Aged10aMolecular Weight10aProteins10aRetinal Vasculitis10aTuberculosis10aUveitis1 aRajesh M1 aSulochana KN1 aSundaram AL1 aKrishnakumar S1 aBiswas J1 aRamakrishnan S00aPresence of a 88 kDa Eales protein in uveitis, tuberculosis, leprosy and rheumatoid arthritis. aCR95-90 v93 a
BACKGROUND: Eales disease (ED) is an idiopathic retinal vasculitis affecting young adult males. We have earlier reported the identification, purification and partial characterization of a novel 88 kDa protein found in the serum of patients with ED. The aim of the present study was to look for the 88 kDa protein in serum samples obtained from cases of retinal vasculitis mimicking ED and in other systemic inflammatory diseases.
MATERIAL/METHODS: Serum samples from healthy volunteers and from patients with ED, uveitis, parsplanitis ocular sarcoidosis, toxoplasmosis, leprosy, diabetic retinopathy, viral hepatitis, and rheumatoid arthritis were analyzed for the presence of the 88 kDa protein by polyacralymide gel electrophoresis (PAGE). The immunological identity of the 88 kDa protein found in ED and in other diseases was investigated by Western blot. Immunohistochemistry was performed on epiretinal membranes (ERM) obtained from ED patients to localize the 88 kDa protein.
RESULTS: 88 kDa protein were detected in serum samples obtained from patients with posterior uveitis, tuberculosis, leprosy and rheumatoid arthritis. The 88 kDa protein found in serum from patients with ED is immunologically identical to that found in other systemic inflammatory conditions. 88 kDa protein was localized in inflammatory cells and in nonvascular endothelium in ERMs obtained from patients with ED.
CONCLUSIONS: We have identified a novel acute phase reactant, which is elaborated in ocular and systemic inflammatory conditions other than Eales disease. Further work is necessary to decipher the precise role of the 88 kDa protein in the pathophysiology of these inflammatory diseases.
a1234-1010